Open AccessClinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A 1 chieve study
Author(s) -
Subhash Kumar Wangnoo,
Samit Ghosal,
Shabbir Akhtar,
Raviraj Shetty,
Sudhir Tripathi
Publication year - 2014
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.139239
Subject(s) - insulin detemir , medicine , protamine , insulin glargine , insulin , endocrinology , cohort , type 2 diabetes , pediatrics , diabetes mellitus , heparin
To explore the clinical safety and effectiveness of insulin detemir (IDet) in a subgroup of Indian patients with type 2 diabetes (T2D) switched from either insulin glargine (IGlar) or neutral protamine Hagedorn (NPH) insulin in the 24-week, non-interventional A1chieve study.